18F-PSMA 1007 in Suspected Renal Cell Carcinoma

被引：21
|
作者：
Marafi, Fahad [1 ]
Sasikumar, Arun [2 ]
Al-Terki, Abdullatif [3 ]
Alfeeli, Mahmoud [1 ]
机构：
[1] Jaber Alahmad Ctr Mol Imaging, Shuwaikh, Kuwait
[2] St Gregorios Int Canc Care Ctr, Chengannur, India
[3] Al Amiri Gen Hosp, Kuwait, Kuwait
来源：
CLINICAL NUCLEAR MEDICINE | 2020年 / 45卷 / 05期
关键词：
F-18-PSMA; 1007; renal cell carcinoma; clear cell; PSMA PET; CT; MEMBRANE ANTIGEN; PET/CT;
D O I：
10.1097/RLU.0000000000003002
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
A 60-year-old man with suspected right renal cell carcinoma underwent F-18-FDG PET/CT and F-18 prostate-specific membrane antigen (PSMA) 1007 PET/CT scan. Compared with the F-18-FDG PET/CT scan, F-18-PSMA 1007 PET/CT showed intense tracer concentration in the primary tumor in the right kidney and intense tracer concentration consistently in all lung nodules. Unlike noted in previous pilot studies with Ga-68-PSMA, we observed that the primary renal tumor also showed intense tracer avidity with F-18-PSMA 1007. F-18-PSMA 1007 PET/CT may provide preoperative insight into possible etiology, histopathological probability of tumor type, staging information, and theranostic potentials in evaluation of suspected renal cell carcinoma.
引用
收藏
页码：377 / 378
页数：2
相关论文
共 50 条
  • [31] 68Ga-PSMA vs. 18F-PSMA: Technical and metabolic differences
    Hackl, T. Oliveira
    Durmaz, P.
    Nagy, A.
    Beyer, B.
    Sailer, J.
    Peloschek, P.
    Hoffmann, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S92 - S93
  • [32] Simultaneous production 18F-FDG and other 18F based (18F-NaF, 18F-FES, 18F-PSMA 1007, 18F-FET) radiopharmaceutical drug by a single run of medical cyclotron
    Dadashov, Z.
    Valiyev, M.
    Shukurov, R.
    Balashov, M.
    Novruzov, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S738 - S738
  • [33] Comparison of PET/CT images with 18F-FDG and 18F-PSMA-1007 in relapsed adenoid cystic carcinoma
    Etchebehere, E.
    Sousa, H. S. V.
    Tobar, N.
    Macedo, L. T.
    Kuba, S.
    Santos, A. O.
    Amorim, B. J.
    Lima, C. S. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S868 - S868
  • [34] Biochemical recurrence of prostate cancer, a pictorial comparison of 18F-PSMA and 18F-fluciclovine.
    Kalbi, Deepak
    Zamora, Edgar
    Shokrekhuda, Aspan
    Chun, Kwang
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [35] Incidental Finding of Colon Carcinoma Related to High Uptake in 18F-PSMA-1007 PET
    Arcay, Ayca
    Eiber, Matthias
    Langbein, Thomas
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (07) : 561 - 562
  • [36] Intense 18F-PSMA-1007 Uptake of Splenic Hemangioma
    Jia, Guorong
    Dong, Aisheng
    Cheng, Chao
    Zuo, Changjing
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (02) : e90 - e92
  • [37] Biokinetics and radiation dosimetry of [18F]-PSMA-1007
    Hvittfeldt, E.
    Bjoersdorff, M.
    Oddstig, J.
    Svegborn, S. Leide
    Brolin, G.
    Minarik, D.
    Tragardh, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S137 - S137
  • [38] [ 18 F]-PSMA-1007-PET for evaluation of kidney function
    Rassek, Philipp
    Schaefers, Michael
    Rahbar, Kambiz
    Backhaus, Philipp
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2023, 62 (04): : 244 - 251
  • [39] Partial Volume Correction for Lymph Nodes in 18F-PSMA PET Images
    Schaefferkoetter, J.
    Ortega, C.
    Veit-Haibach, P.
    Metser, U.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S776 - S777
  • [40] The cause of high [18F]PSMA-1007 uptake in the urinary bladder in some of the [18F]PSMA-1007 patients: an explorative, retrospective study
    Allach, Y.
    Prive, B.
    van Gemert, W.
    Schilham, M.
    Perk, L. R.
    Gotthardt, M.
    Nagarajah, J.
    Janssen, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S530 - S530
12345